Selected research
Industry Research
Flow Cytometry Testing Technology Service Industry Research Report 2026
Market perspective
The global Flow Cytometry Testing Technology Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Flow Cytometry Testing Technology Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Flow Cytometry Testing Technology Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Flow Cytometry Testing Technology Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Flow Cytometry Testing Technology Service include Bioss, Q2 Solutions, KMD Bioscience, Thermo Fisher Scientific Inc, BD, Creative Bioarray, Labcorp, RayBiotech and Sysmex Corporation, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Flow Cytometry Testing Technology Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Flow Cytometry Testing Technology Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Flow Cytometry Testing Technology Service Market by Company
Bioss
Q2 Solutions
KMD Bioscience
Thermo Fisher Scientific Inc
BD
Creative Bioarray
Labcorp
RayBiotech
Sysmex Corporation
Abace Biotechnology
Multi Sciences (Lianke) Biotech Co., Ltd
Shanghai Yingbai Biotechnology Co., Ltd
COBIOER BIOSCIENCES CO.,LTD
Shanghai Medicilon Inc
Beijing Nuowei Biotechnology Co., Ltd
Wuhan Servicebio Technology Co., Ltd
Flow Cytometry Testing Technology Service Segment by Type
Analytical
Sorting Type
Flow Cytometry Testing Technology Service Segment by Application
Cell Cycle and Apoptosis Analysis
Immunological Analysis
Cell Typing Analysis
Other Fluorescence-Based Cytology Assays
Flow Cytometry Testing Technology Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flow Cytometry Testing Technology Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Flow Cytometry Testing Technology Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flow Cytometry Testing Technology Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Flow Cytometry Testing Technology Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Analytical
- Sorting Type
Applications
- Cell Cycle and Apoptosis Analysis
- Immunological Analysis
- Cell Typing Analysis
- Other Fluorescence-Based Cytology Assays
Companies covered
- Bioss
- Q2 Solutions
- KMD Bioscience
- Thermo Fisher Scientific Inc
- BD
- Creative Bioarray
- Labcorp
- RayBiotech
- Sysmex Corporation
- Abace Biotechnology
- Multi Sciences (Lianke) Biotech Co., Ltd
- Shanghai Yingbai Biotechnology Co., Ltd
- COBIOER BIOSCIENCES CO.,LTD
- Shanghai Medicilon Inc
- Beijing Nuowei Biotechnology Co., Ltd
- Wuhan Servicebio Technology Co., Ltd
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Flow Cytometry Testing Technology Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Analytical
- 2.2.3 Sorting Type
- 2.3 Flow Cytometry Testing Technology Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Cell Cycle and Apoptosis Analysis
- 2.3.3 Immunological Analysis
- 2.3.4 Cell Typing Analysis
- 2.3.5 Other Fluorescence-Based Cytology Assays
- 2.4 Assumptions and Limitations
3 Flow Cytometry Testing Technology Service Breakdown Data by Type
- 3.1 Global Flow Cytometry Testing Technology Service Historic Market Size by Type (2021-2026)
- 3.2 Global Flow Cytometry Testing Technology Service Forecasted Market Size by Type (2027-2032)
4 Flow Cytometry Testing Technology Service Breakdown Data by Application
- 4.1 Global Flow Cytometry Testing Technology Service Historic Market Size by Application (2021-2026)
- 4.2 Global Flow Cytometry Testing Technology Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Flow Cytometry Testing Technology Service Market Perspective (2021-2032)
- 5.2 Global Flow Cytometry Testing Technology Service Growth Trends by Region
- 5.2.1 Global Flow Cytometry Testing Technology Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Flow Cytometry Testing Technology Service Historic Market Size by Region (2021-2026)
- 5.2.3 Flow Cytometry Testing Technology Service Forecasted Market Size by Region (2027-2032)
- 5.3 Flow Cytometry Testing Technology Service Market Dynamics
- 5.3.1 Flow Cytometry Testing Technology Service Industry Trends
- 5.3.2 Flow Cytometry Testing Technology Service Market Drivers
- 5.3.3 Flow Cytometry Testing Technology Service Market Challenges
- 5.3.4 Flow Cytometry Testing Technology Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Flow Cytometry Testing Technology Service Players by Revenue
- 6.1.1 Global Top Flow Cytometry Testing Technology Service Players by Revenue (2021-2026)
- 6.1.2 Global Flow Cytometry Testing Technology Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Flow Cytometry Testing Technology Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Flow Cytometry Testing Technology Service Head Office and Area Served
- 6.4 Global Flow Cytometry Testing Technology Service Players, Product Type & Application
- 6.5 Global Flow Cytometry Testing Technology Service Manufacturers Established Date
- 6.6 Global Flow Cytometry Testing Technology Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Flow Cytometry Testing Technology Service Market Size (2021-2032)
- 7.2 North America Flow Cytometry Testing Technology Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Flow Cytometry Testing Technology Service Market Size by Country (2021-2026)
- 7.4 North America Flow Cytometry Testing Technology Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Flow Cytometry Testing Technology Service Market Size (2021-2032)
- 8.2 Europe Flow Cytometry Testing Technology Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Flow Cytometry Testing Technology Service Market Size by Country (2021-2026)
- 8.4 Europe Flow Cytometry Testing Technology Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Flow Cytometry Testing Technology Service Market Size (2021-2032)
- 9.2 Asia-Pacific Flow Cytometry Testing Technology Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Flow Cytometry Testing Technology Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Flow Cytometry Testing Technology Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Flow Cytometry Testing Technology Service Market Size (2021-2032)
- 10.2 South America Flow Cytometry Testing Technology Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Flow Cytometry Testing Technology Service Market Size by Country (2021-2026)
- 10.4 South America Flow Cytometry Testing Technology Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Flow Cytometry Testing Technology Service Market Size (2021-2032)
- 11.2 Middle East & Africa Flow Cytometry Testing Technology Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Flow Cytometry Testing Technology Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Flow Cytometry Testing Technology Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Bioss
- 12.1.1 Bioss Company Information
- 12.1.2 Bioss Business Overview
- 12.1.3 Bioss Revenue in Flow Cytometry Testing Technology Service Business (2021-2026)
- 12.1.4 Bioss Flow Cytometry Testing Technology Service Product Portfolio
- 12.1.5 Bioss Recent Developments
- 12.2 Q2 Solutions
- 12.2.1 Q2 Solutions Company Information
- 12.2.2 Q2 Solutions Business Overview
- 12.2.3 Q2 Solutions Revenue in Flow Cytometry Testing Technology Service Business (2021-2026)
- 12.2.4 Q2 Solutions Flow Cytometry Testing Technology Service Product Portfolio
- 12.2.5 Q2 Solutions Recent Developments
- 12.3 KMD Bioscience
- 12.3.1 KMD Bioscience Company Information
- 12.3.2 KMD Bioscience Business Overview
- 12.3.3 KMD Bioscience Revenue in Flow Cytometry Testing Technology Service Business (2021-2026)
- 12.3.4 KMD Bioscience Flow Cytometry Testing Technology Service Product Portfolio
- 12.3.5 KMD Bioscience Recent Developments
- 12.4 Thermo Fisher Scientific Inc
- 12.4.1 Thermo Fisher Scientific Inc Company Information
- 12.4.2 Thermo Fisher Scientific Inc Business Overview
- 12.4.3 Thermo Fisher Scientific Inc Revenue in Flow Cytometry Testing Technology Service Business (2021-2026)
- 12.4.4 Thermo Fisher Scientific Inc Flow Cytometry Testing Technology Service Product Portfolio
- 12.4.5 Thermo Fisher Scientific Inc Recent Developments
- 12.5 BD
- 12.5.1 BD Company Information
- 12.5.2 BD Business Overview
- 12.5.3 BD Revenue in Flow Cytometry Testing Technology Service Business (2021-2026)
- 12.5.4 BD Flow Cytometry Testing Technology Service Product Portfolio
- 12.5.5 BD Recent Developments
- 12.6 Creative Bioarray
- 12.6.1 Creative Bioarray Company Information
- 12.6.2 Creative Bioarray Business Overview
- 12.6.3 Creative Bioarray Revenue in Flow Cytometry Testing Technology Service Business (2021-2026)
- 12.6.4 Creative Bioarray Flow Cytometry Testing Technology Service Product Portfolio
- 12.6.5 Creative Bioarray Recent Developments
- 12.7 Labcorp
- 12.7.1 Labcorp Company Information
- 12.7.2 Labcorp Business Overview
- 12.7.3 Labcorp Revenue in Flow Cytometry Testing Technology Service Business (2021-2026)
- 12.7.4 Labcorp Flow Cytometry Testing Technology Service Product Portfolio
- 12.7.5 Labcorp Recent Developments
- 12.8 RayBiotech
- 12.8.1 RayBiotech Company Information
- 12.8.2 RayBiotech Business Overview
- 12.8.3 RayBiotech Revenue in Flow Cytometry Testing Technology Service Business (2021-2026)
- 12.8.4 RayBiotech Flow Cytometry Testing Technology Service Product Portfolio
- 12.8.5 RayBiotech Recent Developments
- 12.9 Sysmex Corporation
- 12.9.1 Sysmex Corporation Company Information
- 12.9.2 Sysmex Corporation Business Overview
- 12.9.3 Sysmex Corporation Revenue in Flow Cytometry Testing Technology Service Business (2021-2026)
- 12.9.4 Sysmex Corporation Flow Cytometry Testing Technology Service Product Portfolio
- 12.9.5 Sysmex Corporation Recent Developments
- 12.10 Abace Biotechnology
- 12.10.1 Abace Biotechnology Company Information
- 12.10.2 Abace Biotechnology Business Overview
- 12.10.3 Abace Biotechnology Revenue in Flow Cytometry Testing Technology Service Business (2021-2026)
- 12.10.4 Abace Biotechnology Flow Cytometry Testing Technology Service Product Portfolio
- 12.10.5 Abace Biotechnology Recent Developments
- 12.11 Multi Sciences (Lianke) Biotech Co., Ltd
- 12.11.1 Multi Sciences (Lianke) Biotech Co., Ltd Company Information
- 12.11.2 Multi Sciences (Lianke) Biotech Co., Ltd Business Overview
- 12.11.3 Multi Sciences (Lianke) Biotech Co., Ltd Revenue in Flow Cytometry Testing Technology Service Business (2021-2026)
- 12.11.4 Multi Sciences (Lianke) Biotech Co., Ltd Flow Cytometry Testing Technology Service Product Portfolio
- 12.11.5 Multi Sciences (Lianke) Biotech Co., Ltd Recent Developments
- 12.12 Shanghai Yingbai Biotechnology Co., Ltd
- 12.12.1 Shanghai Yingbai Biotechnology Co., Ltd Company Information
- 12.12.2 Shanghai Yingbai Biotechnology Co., Ltd Business Overview
- 12.12.3 Shanghai Yingbai Biotechnology Co., Ltd Revenue in Flow Cytometry Testing Technology Service Business (2021-2026)
- 12.12.4 Shanghai Yingbai Biotechnology Co., Ltd Flow Cytometry Testing Technology Service Product Portfolio
- 12.12.5 Shanghai Yingbai Biotechnology Co., Ltd Recent Developments
- 12.13 COBIOER BIOSCIENCES CO.,LTD
- 12.13.1 COBIOER BIOSCIENCES CO.,LTD Company Information
- 12.13.2 COBIOER BIOSCIENCES CO.,LTD Business Overview
- 12.13.3 COBIOER BIOSCIENCES CO.,LTD Revenue in Flow Cytometry Testing Technology Service Business (2021-2026)
- 12.13.4 COBIOER BIOSCIENCES CO.,LTD Flow Cytometry Testing Technology Service Product Portfolio
- 12.13.5 COBIOER BIOSCIENCES CO.,LTD Recent Developments
- 12.14 Shanghai Medicilon Inc
- 12.14.1 Shanghai Medicilon Inc Company Information
- 12.14.2 Shanghai Medicilon Inc Business Overview
- 12.14.3 Shanghai Medicilon Inc Revenue in Flow Cytometry Testing Technology Service Business (2021-2026)
- 12.14.4 Shanghai Medicilon Inc Flow Cytometry Testing Technology Service Product Portfolio
- 12.14.5 Shanghai Medicilon Inc Recent Developments
- 12.15 Beijing Nuowei Biotechnology Co., Ltd
- 12.15.1 Beijing Nuowei Biotechnology Co., Ltd Company Information
- 12.15.2 Beijing Nuowei Biotechnology Co., Ltd Business Overview
- 12.15.3 Beijing Nuowei Biotechnology Co., Ltd Revenue in Flow Cytometry Testing Technology Service Business (2021-2026)
- 12.15.4 Beijing Nuowei Biotechnology Co., Ltd Flow Cytometry Testing Technology Service Product Portfolio
- 12.15.5 Beijing Nuowei Biotechnology Co., Ltd Recent Developments
- 12.16 Wuhan Servicebio Technology Co., Ltd
- 12.16.1 Wuhan Servicebio Technology Co., Ltd Company Information
- 12.16.2 Wuhan Servicebio Technology Co., Ltd Business Overview
- 12.16.3 Wuhan Servicebio Technology Co., Ltd Revenue in Flow Cytometry Testing Technology Service Business (2021-2026)
- 12.16.4 Wuhan Servicebio Technology Co., Ltd Flow Cytometry Testing Technology Service Product Portfolio
- 12.16.5 Wuhan Servicebio Technology Co., Ltd Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst